Fusion of high B-value diffusion-weighted and T2-weighted MR images increases sensitivity for identification of extraprostatic disease in prostate cancer
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Clinical Imaging
- Vol. 68, 202-209
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO GuidelineJournal of Urology, 2013
- Early Detection of Prostate Cancer: AUA GuidelineJournal of Urology, 2013
- Radical prostatectomy: value of prostate MRI in surgical planningAbdominal Radiology, 2011
- Prostate cancer: Utility of fusion of T2‐weighted and high b‐value diffusion‐weighted images for peripheral zone tumor detection and localizationJournal of Magnetic Resonance Imaging, 2011
- TECHNICAL ARTICLE: Fusion of high b‐value diffusion‐weighted and T2‐weighted MR images improves identification of lymph nodes in the pelvisJournal of Medical Imaging and Radiation Oncology, 2010
- High-b-Value Diffusion-Weighted Imaging at 3 T to Detect Prostate Cancer: Comparisons Between b Values of 1,000 and 2,000 s/mm2American Journal of Roentgenology, 2010
- Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinomaJournal of Magnetic Resonance Imaging, 2009
- Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imagingEuropean Radiology, 2009
- Imaging Localized Prostate Cancer: Current Approaches and New DevelopmentsAmerican Journal of Roentgenology, 2009
- Body Diffusion-Weighted MR Imaging Using High b-Value for Malignant Tumor Screening: Usefulness and Necessity of Referring to T2-Weighted Images and Creating Fusion ImagesAcademic Radiology, 2007